Cargando…

B Cells as an Immune-Regulatory Signature in Ovarian Cancer

Increasing evidence suggests that the immune system plays a dynamic role in the progression of ovarian cancer, the deadliest gynecological malignancy worldwide. Accumulation of tumor-infiltrating lymphocytes has been associated with increased survival in ovarian cancer patients, and diverse interact...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gupta, Prachi, Chen, Changliang, Chaluvally-Raghavan, Pradeep, Pradeep, Sunila
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678944/ https://www.ncbi.nlm.nih.gov/pubmed/31248034 http://dx.doi.org/10.3390/cancers11070894

Ejemplares similares

Emerging Role of Extracellular Vesicles in Immune Regulation and Cancer Progression
por: Mittal, Sonam, et al.
Publicado: (2020)

Extracellular vesicle contents as non-invasive biomarkers in ovarian malignancies
por: McAlarnen, Lindsey A., et al.
Publicado: (2022)

Metabolic Reprogramming in Tumor-Associated Macrophages in the Ovarian Tumor Microenvironment
por: Kumar, Sudhir, et al.
Publicado: (2022)

ERBB signaling in CTCs of ovarian cancer and glioblastoma
por: Geethadevi, Anjali, et al.
Publicado: (2017)

ERBB3-induced furin promotes the progression and metastasis of ovarian cancer via the IGF1R/STAT3 signaling axis
por: Chen, Changliang, et al.
Publicado: (2020)

Optimized proximity ligation assay (PLA) for detection of RNA-protein complex interactions in cell lines
por: George, Jasmine, et al.
Publicado: (2022)

Patient-Derived Ovarian Cancer Spheroids Rely on PI3K-AKT Signaling Addiction for Cancer Stemness and Chemoresistance
por: Parashar, Deepak, et al.
Publicado: (2022)

Tumor Derived Extracellular Vesicles Drive T Cell Exhaustion in Tumor Microenvironment through Sphingosine Mediated Signaling and Impacting Immunotherapy Outcomes in Ovarian Cancer
por: Gupta, Prachi, et al.
Publicado: (2022)

Correction: Parashar et al. Patient-Derived Ovarian Cancer Spheroids Rely on PI3K-AKT Signaling Addiction for Cancer Stemness and Chemoresistance. Cancers 2022, 14, 958
por: Parashar, Deepak, et al.
Publicado: (2022)

Targeting ncRNAs in the 3q26.2 amplicon
por: Chaluvally-Raghavan, Pradeep, et al.
Publicado: (2015)

RNA-binding protein FXR1 drives cMYC translation by recruiting eIF4F complex to the translation start site
por: George, Jasmine, et al.
Publicado: (2021)

Preclinical activity of selinexor in combination with eribulin in uterine leiomyosarcoma
por: Mittal, Sonam, et al.
Publicado: (2023)

Targeted biologic inhibition of both tumor cell-intrinsic and intercellular CLPTM1L/CRR9-mediated chemotherapeutic drug resistance
por: Parashar, Deepak, et al.
Publicado: (2021)

A recombinant decoy comprising EGFR and ErbB-4 inhibits tumor growth and metastasis
por: Lindzen, Moshit, et al.
Publicado: (2011)

ADAMTS16 mutations sensitize ovarian cancer cells to platinum-based chemotherapy
por: Yasukawa, Maya, et al.
Publicado: (2016)

ADH1B promotes mesothelial clearance and ovarian cancer infiltration
por: Gharpure, Kshipra M., et al.
Publicado: (2018)

An ensemble model of QSAR tools for regulatory risk assessment
por: Pradeep, Prachi, et al.
Publicado: (2016)

Nanotechnology and Glycosaminoglycans: Paving the Way Forward for Ovarian Cancer Intervention
por: Hoosen, Yasar, et al.
Publicado: (2018)

Regulatory T Cells in Human Ovarian Cancer
por: Peng, Dong-Jun, et al.
Publicado: (2012)

Anticancer effect of physical activity is mediated by modulation of extracellular microRNA in blood
por: Pulliero, Alessandra, et al.
Publicado: (2020)

Fluorinated triphenylphosphonium analogs improve cell selectivity and in vivo detection of mito-metformin
por: AbuEid, Mahmoud, et al.
Publicado: (2022)

Metabolic signatures of human breast cancer
por: Mishra, Prachi, et al.
Publicado: (2015)

The role of tumor microenvironment in resistance to anti-angiogenic therapy
por: Ma, Shaolin, et al.
Publicado: (2018)

The tRNA-derived fragment signature in lung cancer
por: Cingaram, Pradeep Reddy
Publicado: (2022)

Developing a genetic signature to predict drug response in ovarian cancer
por: Hyter, Stephen, et al.
Publicado: (2017)

Identification of the Immune Signatures for Ovarian Cancer Based on the Tumor Immune Microenvironment Genes
por: Shen, Xiaoyan, et al.
Publicado: (2022)

1-Methylnicotinamide is an immune regulatory metabolite in human ovarian cancer
por: Kilgour, Marisa K., et al.
Publicado: (2021)

Regulatory T-cell heterogeneity and the cancer immune response
por: Ward-Hartstonge, Kirsten A, et al.
Publicado: (2017)

Ferroptosis gene signature in cholangiocarcinoma
por: Cingaram, Pradeep Reddy
Publicado: (2022)

Immune-related gene expression signatures in colorectal cancer
por: Sun, Zhenqing, et al.
Publicado: (2021)

Regulatory Role of the Adipose Microenvironment on Ovarian Cancer Progression
por: Chehade, Hussein, et al.
Publicado: (2022)

The potential regulatory role of RNA methylation in ovarian cancer
por: Zhao, Shijie, et al.
Publicado: (2023)

Dynamic TF-lncRNA Regulatory Networks Revealed Prognostic Signatures in the Development of Ovarian Cancer
por: Guo, Qiuyan, et al.
Publicado: (2020)

Regulatory T Cells in Ovarian Carcinogenesis and Future Therapeutic Opportunities
por: Cassar, Emily, et al.
Publicado: (2022)

Development and validation of an immune gene-set based Prognostic signature in ovarian cancer
por: Shen, Sipeng, et al.
Publicado: (2018)

Comprehensive analysis of prognostic gene signatures based on immune infiltration of ovarian cancer
por: Yan, Shibai, et al.
Publicado: (2020)

Development of a necroptosis-related gene signature and the immune landscape in ovarian cancer
por: Nie, Sipei, et al.
Publicado: (2023)

The Roles of Regulatory B Cells in Cancer
por: He, Yan, et al.
Publicado: (2014)

Synthesis and Properties of CurNQ for the Theranostic Application in Ovarian Cancer Intervention
por: Freidus, Lara G., et al.
Publicado: (2020)

Tumor T(1) Relaxation Time for Assessing Response to Bevacizumab Anti-Angiogenic Therapy in a Mouse Ovarian Cancer Model
por: Ravoori, Murali K., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_m3jgjomhge04cig1nhu4ob45ku